Nebulizer Market: Industry Analysis and Forecast (2021-2027)

Mayurikathade03 Jun, 2022Business

Pharmacovigilance Market is anticipated to reach US$ 12.16 Bn .by 2027 from US$ 6.33 Bn. in 2020 at a CAGR of 11.5% during a forecast period. Rising acceptance and usage of outsourcing services by healthcare firms is likely to boost the market growth. Furthermore, the increased popularity of outsourcing PV services due to cost savings is expected to fuel market growth throughout the forecast period. The growing danger of COVID-19 infection is having a positive impact on market growth. Because multiple possible medications are being tried to treat COVID-19-induced infection, medical monitoring and safety reporting are critical. COVID-19 infection is being treated with drugs including hydroxychloroquine (HCQ), Remdesivir, and Lopinavir/Ritonavir. The possibility of potential adverse drug reactions for some of these drugs has previously been reported to the Uppsala Monitoring Centre's case safety reporting database, VigiBase (UMC).